TG THERAPEUTICS, INC. (TGTX) Total liabilities 2016–2025
TG THERAPEUTICS, INC. (TGTX) total liabilities at each fiscal year-end, per SEC filings.
$415.2MFY2025 · since FY2016: $18.9M → $415.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $415.2M | +16.9% |
| FY2024 | $355.3M | +110.1% |
| FY2023 | $169.1M | +25.3% |
| FY2022 | $135.0M | -5.3% |
| FY2021 | $142.5M | +34.0% |
| FY2020 | $106.3M | -14.6% |
| FY2019 | $124.4M | +108.8% |
| FY2018 | $59.6M | +96.1% |
| FY2017 | $30.4M | +60.7% |
| FY2016 | $18.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TGTX financial trends
TGTX RevenueTGTX Net incomeTGTX Net marginTGTX Gross profitTGTX Gross marginTGTX Operating incomeTGTX Operating marginTGTX Operating cash flowTGTX Free cash flowTGTX Capital expendituresTGTX Return on equityTGTX Stock buybacksTGTX Dividends paidTGTX Total assetsTGTX Shareholders’ equityTGTX overview →